CoChat

Churg-Strauss syndrome: update on recent developments

Gross, W. L. · 2002 · Current Opinion in Rheumatology

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Churg-Strauss syndrome (CSS) is a form of primary vasculitis characterized by allergy and angiitis. In the organ systems involved (lung, heart, peripheral nervous system, and so forth), eosinophilic infiltration can be found. Eosinophilia and normochromic normocytic anemia are leading laboratory findings together with elevated IgE. New seromarkers for the activation of endothelial cells, lymphocytes, and eosinophils (soluble thrombomodulin, soluble interleukin-2 receptor, eosinophil cationic protein) may be able to predict a relapse. Antineutrophil cytoplasmic antibodies are found in only approximately 50% of all patients with CSS, and their diagnostic value is questionable. Etiologically, hyperresponsiveness to an antigenic stimulus seems to underlie the syndrome. In asthmatics, cysteinyl leukotriene receptor type 1 antagonists are reported to trigger the disease. Cytokine profile findings on the cells involved in CSS remain contradictory. Some think CSS may be a Th2-mediated disease; its pathophysiology is not known fully. Interleukin-5 and tumor necrosis factor-alpha are elevated in serum and fluid of bronchoalveolar lavage, suggesting target cytokines for future treatment protocols. Treatment consists of glucocorticoid monotherapy. Data on outcome and effectiveness is lacking for other immunosuppressive regimens, such as cyclophosphamide or glucocorticoid plus cyclophosphamide. Treatment with interferon-alpha has been effective in patients refractory to glucocorticoid plus cyclophosphamide.

Overview

Integrity signals

Registry

Crossref · 10.1097/00002281-200201000-00003

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 5

  1. Reinhold-Keller, 2000, Clin Exp Immunol, 120, 18
  2. Schmitt, 1998, Clin Exp Immunol, 112, 32
  3. Hurst, 2000, Clin Exp Rheumatol, 18, 784
  4. Schönermarck, 2000, Clin Exp Rheumatol, 18, 457
  5. Hart, 1998, Eur Respir Rev, 63, 1056

Cited by

See all 60

Metadata

Authors
Gross, W. L.
Affiliations
University of Lübeck (DE)
Corresponding author
Gross, W. L.
Venue
Current Opinion in Rheumatology
Published
2002-01
Volume
14
Issue
1
Pages
11-14
ISSN
1040-8711 (ISSN-L)
OpenAlex
W2329533764
Cited by
60
References
37
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2018: 3 · 2016: 3 · 2014: 1 · 2013: 1 · 2012: 5
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Rheumatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
  • Health Sciences › Medicine › Rheumatology › Eosinophilic Disorders and Syndromes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords
eosinophilic granulomatosis with polyangiitis, primary vasculitis, eosinophilia, eosinophil infiltration, soluble thrombomodulin, soluble interleukin-2 receptor, eosinophil cationic protein, antineutrophil cytoplasmic antibodies, IL-5, TNF-α, glucocorticoid therapy, cyclophosphamide, interferon-alpha, recurrence prediction, cytokine profile
MeSH terms
Adrenal Cortex Hormones, Humans, Churg-Strauss Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Churg-Strauss syndrome: update on recent developments. https://app.cochat.ai/papers/10.1097/00002281-200201000-00003
The paper
Gross, W. L. (2002). Churg-Strauss syndrome: update on recent developments. Current Opinion in Rheumatology. https://doi.org/10.1097/00002281-200201000-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.